Overview

Raised to Date: Raised: $357,719

Total Commitments ($USD)

Platform

StartEngine

Start Date

08/02/2022

Close Date

09/01/2022

Min. Goal
$9,999
Max. Goal
$1,000,085
Min. Investment

$194

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$8.81

Pre-Money Valuation

$81,236,323

Rolling Commitments ($USD)

Status
Funded
Reporting Date

09/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$12,335

# of Investors

273

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2019

Industry

Fitness & Wellness

Tech Sector

Medtech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

High

Location

Brooklyn, New York

Business Type

Growth

Fisher Wallace Laboratories, with a valuation of $81.2 million, is raising funds on StartEngine. The company manufactures and sells wearable medical devices for mood and sleep disorders, including insomnia, anxiety, and depression. The product of Fisher Wallace Laboratories, Fisher Wallace Stimulator, stimulates the brain to produce serotonin and modulates brainwave activity. The company has generated $40 million in lifetime revenue and has 14,000 prescribers. Kelly Roman and Charles Fisher founded Fisher Wallace Laboratories in August 2019. The current crowdfunding campaign has a minimum target of $9,999.35 and a maximum target of $1,000,084.77. The campaign proceeds will be used to release OAK (Version 2) and expand.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$4,230,290

$4,250,866

COGS

$623,703

$970,761

Tax

$250

$1,597

 

 

Net Income

$-3,262,291

$-1,823,732

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,929,380

$695,749

Accounts Receivable

$0

$2,302

Total Assets

$1,999,403

$853,359

Short-Term Debt

$471,468

$725,122

Long-Term Debt

$576,525

$620,416

Total Liabilities

$1,047,993

$1,345,538

Financials as of: 08/02/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Fisher Wallace 04/17/2024 Dealmaker Securities $104,100,000 $413,448 Equity - Common Funded RegCF
Fisher Wallace 03/11/2024 Dealmaker Securities $102,658,809 $469,069 Equity - Common Funded RegCF
Fisher Wallace 01/23/2024 Dealmaker Securities $102,170,000 $532,202 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/03/2023 StartEngine $100,280,000 $493,354 Equity - Common Funded RegA+
Fisher Wallace 02/19/2023 StartEngine $81,567,588 $1,281,201 Equity - Common Funded RegCF
Fisher Wallace Laboratories 08/31/2022 StartEngine $81,236,323 $357,719 Equity - Common Funded RegCF
Fisher Wallace Laboratories 05/26/2022 StartEngine $80,048,889 $1,279,724 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/25/2021 StartEngine $40,000,000 $5,010,683 Equity - Common Funded RegA+
Fisher Wallace Laboratories 03/08/2020 StartEngine $15,000,000 $1,056,480 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Fisher Wallace Laboratories on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $81,236,323
Price per Share: $8.81

Follow company

Follow Fisher Wallace Laboratories on StartEngine 2022

Buy Fisher Wallace Laboratories's Deal Report

Warning: according to the close date for this deal, Fisher Wallace Laboratories may no longer be accepting investments.

Fisher Wallace Laboratories Deal Report

Get KingsCrowd’s comprehensive report on Fisher Wallace Laboratories including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Fisher Wallace Laboratories is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Fisher Wallace Laboratories deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge